Insmed, Inc. (INSM)
114.40
+5.64
(+5.19%)
USD |
NASDAQ |
Nov 06, 16:00
114.48
+0.08
(+0.07%)
After-Hours: 20:00
Insmed EPS Diluted (TTM) : -2.816 for Sept. 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -2.816 |
| June 30, 2026 | -4.105 |
| March 31, 2026 | -5.743 |
| December 31, 2025 | -6.403 |
| September 30, 2025 | -6.181 |
| June 30, 2025 | -5.703 |
| March 31, 2025 | -5.947 |
| December 31, 2024 | -5.587 |
| September 30, 2024 | -5.556 |
| June 30, 2024 | -5.398 |
| March 31, 2024 | -5.235 |
| December 31, 2023 | -5.348 |
| September 30, 2023 | -5.270 |
| June 30, 2023 | -5.244 |
| March 31, 2023 | -4.264 |
| December 31, 2022 | -3.888 |
| September 30, 2022 | -3.634 |
| June 30, 2022 | -3.511 |
| March 31, 2022 | -3.782 |
| December 31, 2021 | -3.876 |
| September 30, 2021 | -3.922 |
| June 30, 2021 | -3.586 |
| March 31, 2021 | -3.155 |
| December 31, 2020 | -3.005 |
| September 30, 2020 | -2.598 |
| Date | Value |
|---|---|
| June 30, 2020 | -2.652 |
| March 31, 2020 | -2.825 |
| December 31, 2019 | -3.042 |
| September 30, 2019 | -3.637 |
| June 30, 2019 | -4.097 |
| March 31, 2019 | -4.284 |
| December 31, 2018 | -4.218 |
| September 30, 2018 | -3.88 |
| June 30, 2018 | -3.43 |
| March 31, 2018 | -3.15 |
| December 31, 2017 | -2.86 |
| September 30, 2017 | -3.11 |
| June 30, 2017 | -3.03 |
| March 31, 2017 | -2.90 |
| December 31, 2016 | -2.84 |
| September 30, 2016 | -2.25 |
| June 30, 2016 | -2.14 |
| March 31, 2016 | -2.02 |
| December 31, 2015 | -2.03 |
| September 30, 2015 | -1.88 |
| June 30, 2015 | -1.92 |
| March 31, 2015 | -2.04 |
| December 31, 2014 | -1.85 |
| September 30, 2014 | -1.90 |
| June 30, 2014 | -1.82 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 19.80 |
| Gilead Sciences, Inc. | -3.149 |
| Incyte Corp. | 1.879 |
| Vertex Pharmaceuticals, Inc. | 15.55 |
| Regeneron Pharmaceuticals, Inc. | 45.30 |